OOIR: Observatory of International Research

Papers

(The TQCC of Brain Tumor Pathology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)

Article	Citations
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation	24
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu	20
Preface for Brain Tumor Pathology vol.41 issue 2	15
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis	14
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma	12
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma	12
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment	12
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature	12
Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies	9
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next	8
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym	7
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next	7
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation	6
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors	6
Exploratory analysis of miRNAs-21, -26a, -34a, -181c, -181d, and -485-5p as potential biomarkers for tumor treating fields sensitivity in primary glioblastoma cell cultures	5
Gyriform infiltration indicates tumor invasion burden of isocitrate dehydrogenase 1/2-wildtype gliomas	5
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas	5
Three-dimensional visualization of human brain tumors using the CUBIC technique	5
Biphasic high-grade cerebellar glioma with epithelial-like components: challenges in integrated diagnosis imposed by limited sampling	5
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma	4
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis	4
Rare intracranial mesenchymal tumors with FET::CREB fusions: clinicopathologic spectrum of four cases with integrated molecular analysis and review of the literature	4
Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant	4
Diverse NF2 alterations in cranial schwannomas: a two-case series of germline whole-gene deletion and somatic in-frame deletion	4
Comparative molecular profiles of distinct tumor components in recurrent tentorial meningioma after stereotactic radiosurgery: a case report implicating acquired aggressive alterations associated with	4

Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis	4
Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature	4
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment	4
Rapid immunohistochemistry for intraoperative differentiation between high-grade gliomas and primary central nervous system lymphomas: a multicenter prospective study	4
Meningioma with trabecular architecture: a harbinger of BAP1 deficiency	4
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report	4